Biotechnology Featured Press Releases
-
Abbott Receives FDA Clearance for Chlamydia and Gonorrhea Tests
DES PLAINES, Ill. - June 28, 2010, Abbott (NYSE: ABT) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect...
-
Gainesville Region Receives Support for Allied Health and Biotechnology Jobs from Department of Commerce
WASHINGTON, June 14, 2010 -- U.S. Commerce Secretary Gary Locke today announced a $1.670 million U.S. Economic Development Administration (EDA) grant to Santa Fe College and the District Board of Trustees of Santa Fe College of Gainesville,...
-
Ion Torrent Extending Ion PGM Sequencer Grant Program to Europe
Guilford, CT, and San Francisco, June 11, 2010 -- Ion Torrent today announced that it is extending its Ion PGM Sequencer Grant Program to Europe, and will award two sequencers to scientists there in the second half of 2010. This spring Ion Torrent...
-
LIBYAN AIR CRASH DNA SAMPLES TO TRIMEGA LABORATORIES FOR ANALYSIS
Libyan government instructs UK-based Trimega Laboratories to coordinate DNA analysis and carry out forensic work on the remains of the passengers who died in Afriqiyah Airways Flight 771 crash. The Libyan government has instructed UK-based...
-
New Digital Scanning Technique Detects Breast Cancer in Women Under 50
May 18, 2010 /EIN Presswire/ -- Breast tissue in women younger than 50 tends to be denser and harder for conventional mammogram scans to detect, but a new digital infra-red technique pushes up the detection rate dramatically. The technology...
Biotechnology Live Press Feed
-
China-Biotics Announces September 20 Investor Day Schedule
China-Biotics Announces September 20 Investor Day Schedule PR Newswire SHANGHAI , Sept. 3 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics", the "Company") (Nasdaq: CHBT), the leading developer, manufacturer...
-
The Female Health Company to Present at Rodman & Renshaw's Annual Global Investment Conference on Wednesday, September 15, 2010
The Female Health Company to Present at Rodman & Renshaw's Annual Global Investment Conference on Wednesday, September 15, 2010 PR Newswire CHICAGO , Sept. 3 /PRNewswire/ -- The Female Health Company (Nasdaq: FHCO), which manufactures...
-
MDS to Release Third Quarter 2010 Financial Results
MDS to Release Third Quarter 2010 Financial Results PR Newswire OTTAWA, Sept. 3 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global health science market, today announced...
-
MDS Nordion Appoints Kenneth Newport to its Board of Directors
MDS Nordion Appoints Kenneth Newport to its Board of Directors PR Newswire OTTAWA , Sept. 3 /PRNewswire-FirstCall/ - MDS Nordion, a leader in providing products and services for the global health sciences market, today announced...
-
Biotech Stocks in Spotlight (Orexigen Therapeutics, Inc., VIVUS, Inc., Cell Therapeutics, Inc., PDL BioPharma Inc.)
( EMAILWIRE.COM , September 03, 2010 ) New York, NY-Orexigen Therapeutics, Inc. (NASDAQ:OREX) soared 18.52% to $5.44 on over 8.33 million shares. Orexigen Therapeutics Inc said it sold the North American marketing rights for its experimental...
-
New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets
New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets PR Newswire DALLAS, Texas , September 3, 2010 /PRNewswire/ -- Buy this report now: http://www.marketsandmarkets.com/Market-Reports/digestive-health-ingredients-...
-
Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification
Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification PR Newswire SHANGHAI , Sept. 3 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research...
-
Biotech Stocks to Keep an Eye-On (Dendreon Corporation, Human Genome Sciences, Celgene Corporation, Amgen, Inc.)
( EMAILWIRE.COM , September 02, 2010 ) New York, NY-Dendreon Corporation (NASDAQ:DNDN) soared 6.70% to $38.24 on over 3.49 million shares after The Centers for Medicare and Medicaid Services said that it has called a meeting to consider the...
-
Neuronetics Selected by World Economic Forum as 2011 Technology Pioneer
Neuronetics Selected by World Economic Forum as 2011 Technology Pioneer Novel device for the treatment of depression recognized in the Biotechnology and Health category PR Newswire MALVERN, Pa. , Sept. 2 /PRNewswire/ -- Neuronetics,...
-
Celsion Receives SBIR Grant To Expand Its Technology Platform
Celsion Receives SBIR Grant To Expand Its Technology Platform Activities to focus on additional applications for the Company's unique heat-activated liposomal technology encapsulating carboplatin PR Newswire COLUMBIA, Md. ,...
-
On The Radar: Ohr Pharmaceutical
September 2, 2010 (FinancialWire) (Investrend Information Syndicate) ( Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today’s featured news .) — Healthcare/Biotech company Ohr Pharmaceutical, Inc. ( OHRP.OB ) (Approx. Market...
-
RatePoint CEO Named Mass High Tech 2010 All-Star of New England Innovation Economy
RatePoint CEO Named Mass High Tech 2010 All-Star of New England Innovation Economy PR Newswire BOSTON , Sept. 2 /PRNewswire/ -- Mass High Tech, The Voice of New England Innovation, today announced that Neal Creighton , CEO and...
-
Biotech Companies: Eastland Named CFO At Oncothyreon
September 2, 2010 (FinancialWire) ( Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today’s featured news .) — Oncothyreon, Inc. (NASDAQ: ONTY) has appointed Julie M. Eastland as chief financial officer and VP of corporate development....
-
Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development
Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development Sessions Designed To Help Organizations Decrease Study Timelines and Reduce Costs in Bringing Drugs to Market PR Newswire CARY, N.C....
-
New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments
New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments Beike Biotechnology and Medistem, Inc. Report on 114 Patients Treated With Novel Cord Blood Stem Cell Protocol; New Approach Opens Door to Expanded Uses of Cord...
Presswire
- Key Energy Services to Present at the Raymond James 6th Annual European Investors Conference [03 Sep 2010] PR Newswire


